AKANAkanda Corp. Common Shares

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · akandacorp.com

3.860USDMkt Cap: 2.09M $P/E: —3d ago

Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and t…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap2.09M $

Enterprise Value15.56M $

Revenue (TTM)258.07K $

Gross Profit-156.02K $

Net Income (TTM)-45.65M $

Revenue/Share3.743 USD

Last Price3.860 USD

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees—

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-3.31

EV/Revenue60.29

P/S8.09

P/B-0.25

EPS (TTM)-15065.55

EPS (Forward)—

52W Range

3.77039% of range4.000

52W High4.000 USD

52W Low3.770 USD

Profitability

Gross Margin-60.46%

Oper. Margin-1353.34%

EBITDA Margin0.00%

Profit Margin-17690.19%

ROE423.31%

ROA-736.88%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-6.73M $

CapEx (TTM)1.23M $

FCF Margin-2212.52%

FCF Yield-273.51%

Net Debt13.73M $

Net Debt/EBITDA-2.92

Balance Sheet

Debt/Equity-1.32

Current Ratio0.58

Quick Ratio0.31

Book Value/Sh-15.5850 USD

Cash/Share0.6410 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split222:1000

Split DateApr 13, 2026

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.540.84K

Float537.66K

Insiders0.59%

Institutions0.15%

Short Interest

Short Ratio0.1d

Short % Float3.20%

Short % Out.3.18%

Shares Short17.22K

Short (prev mo.)18.18K

Technical

SMA 509.697 (-60.2%)

SMA 20012.44 (-69.0%)

Beta14.23

S&P 52W Chg19.18%

Avg Vol (30d)157.25K

Avg Vol (10d)2.73M

Technical Indicators

RSI (14)30.5

MACD-1.4512

MACD Signal-1.6001

MACD Hist.+0.1489

BB Upper6.757 USD

BB Middle5.261 USD

BB Lower3.765 USD

BB Width56.88%

ATR (14)1.099 USD

Vol Ratio (20d)0.09x